Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 47 Neutropenia 26 Lymphoma 25 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Neoplasms 11 Sarcoma 9 Lymphoma, Follicular 9 Ovarian Neoplasms 8 Lymphoma, Mantle-Cell 8 Leukemia 8 Hodgkin Disease 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Triple Negative Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Lymphoma, B-Cell, Marginal Zone 5 Chemotherapy-induced Neutropenia 5 Rhabdomyosarcoma 4 Neoplasm Metastasis 4 Lymphoma, Large-Cell, Immunoblastic 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Urinary Bladder Neoplasms 3 Testicular Neoplasms 3 Sarcoma, Synovial 3 Prostatic Neoplasms 3 Neurofibrosarcoma 3

Interventions

Cyclophosphamide 12 Whole-Body Irradiation 10 fludarabine phosphate 9 Rituximab 9 Peripheral Blood Stem Cell Transplantation 9 Cyclosporine 9 Mycophenolic Acid 7 Filgrastim 7 Etoposide 6 Dexamethasone 6 Busulfan 6 Methotrexate 5 Tacrolimus 4 Carboplatin 4 Bortezomib 4 Vorinostat 3 Thiotepa 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Calcium Dobesilate 3 merphos 2 liposomal amphotericin B 2 laromustine 2 ixabepilone 2 entinostat 2 Transplantation 2 Therapeutics 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × pegfilgrastim × Clear all

NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡